Pegasus Asset Management, Inc. / EW
Pegasus Asset Management, Inc.’s Edwards Lifesciences Corp Position
Does Pegasus Asset Management, Inc. own Edwards Lifesciences Corp (EW)? Not currently — the last reported position was 42.6K shares worth $3M in Q4 2024; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$3M
Q4 2024
Shares
42.6K
% of Portfolio
+1.19%
Quarters Held
25
position exited
Position History EW
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2024 | 42.6K | $3M | +1.19% |
| Q3 2024 | 42.5K | $3M | +1.07% |
| Q2 2024 | 43.3K | $4M | +1.53% |
| Q1 2024 | 42.7K | $4M | +1.58% |
| Q4 2023 | 42.8K | $3M | +1.40% |
| Q3 2023 | 41.7K | $3M | +1.34% |
| Q2 2023 | 41.5K | $4M | +1.74% |
| Q1 2023 | 41.8K | $3M | +1.71% |
| Q4 2022 | 41.8K | $3M | +1.69% |
| Q3 2022 | 41.6K | $3M | +1.94% |
| Q2 2022 | 42.1K | $4M | +2.18% |
| Q1 2022 | 43.3K | $5M | +2.21% |
| Q4 2021 | 43.7K | $6M | +2.32% |
| Q3 2021 | 43.5K | $5M | +2.26% |
| Q2 2021 | 43.5K | $5M | +2.10% |
| Q1 2021 | 43.7K | $4M | +1.85% |
| Q4 2020 | 42.3K | $4M | +2.11% |
| Q3 2020 | 42.2K | $3M | +2.11% |
| Q2 2020 | 42.1K | $3M | +1.99% |
| Q1 2020 | 14.1K | $3M | +2.20% |
| Q4 2019 | 14.0K | $3M | +2.14% |
| Q3 2019 | 14.2K | $3M | +2.26% |
| Q2 2019 | 14.1K | $3M | +2.02% |
| Q1 2019 | 14.1K | $3M | +2.22% |
| Q4 2018 | 14.3K | $2M | +2.07% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Pegasus Asset Management, Inc.’s full portfolio or all institutional holders of EW.